{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T15:19:39Z","timestamp":1783696779398,"version":"3.55.0"},"reference-count":67,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2014,6,9]],"date-time":"2014-06-09T00:00:00Z","timestamp":1402272000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,6,9]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>In different bioassays, functional antibodies reacting with the human muscarinic acetylcholine receptor M3(mAchR3) have been detected in sera from patients with Sj\u00f6gren's syndrome (SS), and there is strong evidence that those antibodies may have pathogenetic relevance. However, depending on the method of detection, their prevalence varied. Furthermore, those bioassays are difficult to standardize. We report on the development and optimization of a novel test system based on a luminometric method to determine downstream signalling of mAchR3 which produces specific and reproducible results. Chinese hamster ovarian (CHO) cells were transfected with plasmids encoding mAchR3 and a green fluorescence protein (GFP)\/aequorin fusion protein. Incubation of cells with carbachol resulted in an increase in intracellular [Ca2+], which was detected by measuring light emission with a luminometer, and the effect of incubation with patients' immunoglobulins (Ig) was evaluated. Optimal cell density, Ig preparation and time of incubation with patients' sera were determined. Sera from patients with primary Sj\u00f6gren's syndrome (pSS; n = 40), systemic sclerosis (SSc; n = 47), myasthenia gravis (MG; n = 133) and 50 blood donors were analysed. Optimal assay conditions were obtained with a cell density of 100 000 cells\/ml, isolation of Ig by ammonium sulphate precipitation and short-term incubation. Based on this highly reliable assay, 50% of the pSS patients had antibodies which inhibited carbachol-induced activation of mAchR3; none of the SSc patients, 6% of the patients with MG and 12% of the blood donors had antibodies which reacted with the mAchR3. This method facilitates the determination of functional anti-mAchR3 antibodies in patients' sera, confirmed their high prevalence in pSS patients and may, therefore, help to analyse their pathogenetic and clinical relevance in more detail.<\/jats:p>","DOI":"10.1111\/cei.12324","type":"journal-article","created":{"date-parts":[[2014,3,17]],"date-time":"2014-03-17T09:52:55Z","timestamp":1395049975000},"page":"179-189","source":"Crossref","is-referenced-by-count":17,"title":["A novel luminescence-based method for the detection of functionally active antibodies to muscarinic acetylcholine receptors of the M3 type (mAchR3) in patients' sera"],"prefix":"10.1093","volume":"177","author":[{"given":"B","family":"Preuss","sequence":"first","affiliation":[{"name":"Department of Internal Medicine II, University of Tuebingen, Tuebingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Tunaru","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Max-Planck-Institute for Heart and Lung Research, Bad Nauheim, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Henes","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine II, University of Tuebingen, Tuebingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Offermanns","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Max-Planck-Institute for Heart and Lung Research, Bad Nauheim, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Klein","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine II, University of Tuebingen, Tuebingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2014,6,9]]},"reference":[{"key":"2021122010061718200_cei12324-bib-0001","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1056\/NEJMra0905750","article-title":"Graves' ophthalmopathy","volume":"362","author":"Bahn","year":"2010","journal-title":"N Engl J Med"},{"key":"2021122010061718200_cei12324-bib-0002","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3109\/08916930903555943","article-title":"Antibody effector mechanisms in myasthenia gravis-pathogenesis at the neuromuscular junction","volume":"43","author":"Gomez","year":"2010","journal-title":"Autoimmunity"},{"key":"2021122010061718200_cei12324-bib-0003","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1055\/s-0030-1251506","article-title":"Targeting receptor antibodies in immune cardiomyopathy","volume":"36","author":"Jahns","year":"2010","journal-title":"Semin Thromb Hemost"},{"key":"2021122010061718200_cei12324-bib-0004","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1046\/j.1365-2249.1996.42748.x","article-title":"Circulating antibodies against rat parotid gland M3 muscarinic receptors in primary Sjogren's syndrome","volume":"104","author":"Bacman","year":"1996","journal-title":"Clin Exp Immunol"},{"key":"2021122010061718200_cei12324-bib-0005","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1056\/NEJMoa052955","article-title":"Stimulatory autoantibodies to the PDGF receptor in systemic sclerosis","volume":"354","author":"Baroni","year":"2006","journal-title":"N Engl J Med"},{"key":"2021122010061718200_cei12324-bib-0006","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1006\/clim.1998.4640","article-title":"Activation of nitric oxide signaling through muscarinic receptors in submandibular glands by primary Sjogren syndrome antibodies","volume":"90","author":"Perez Leiros","year":"1999","journal-title":"Clin Immunol"},{"key":"2021122010061718200_cei12324-bib-0007","doi-asserted-by":"crossref","first-page":"C905","DOI":"10.1152\/ajpcell.1996.271.3.C905","article-title":"Identification of muscarinic receptor subtypes in mouse parotid gland","volume":"271","author":"Watson","year":"1996","journal-title":"Am J Physiol"},{"key":"2021122010061718200_cei12324-bib-0008","first-page":"296","article-title":"Muscarinic acetylcholine type-3 receptor desensitization due to chronic exposure to Sjogren's syndrome-associated autoantibodies","volume":"33","author":"Cha","year":"2006","journal-title":"J Rheumatol"},{"key":"2021122010061718200_cei12324-bib-0009","doi-asserted-by":"crossref","first-page":"2984","DOI":"10.1002\/art.21347","article-title":"Antimuscarinic antibodies in Sjogren's syndrome: where are we, and where are we going?","volume":"52","author":"Dawson","year":"2005","journal-title":"Arthritis Rheum"},{"key":"2021122010061718200_cei12324-bib-0010","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1002\/art.21764","article-title":"Antimuscarinic antibodies in primary Sjogren's syndrome reversibly inhibit the mechanism of fluid secretion by human submandibular salivary acinar cells","volume":"54","author":"Dawson","year":"2006","journal-title":"Arthritis Rheum"},{"key":"2021122010061718200_cei12324-bib-0011","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1093\/rheumatology\/ken064","article-title":"Functional epitope of muscarinic type 3 receptor which interacts with autoantibodies from Sjogren's syndrome patients","volume":"47","author":"Koo","year":"2008","journal-title":"Rheumatology"},{"key":"2021122010061718200_cei12324-bib-0012","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.clim.2008.04.001","article-title":"Demonstration of autoantibody binding to muscarinic acetylcholine receptors in the salivary gland in primary Sjogren's syndrome","volume":"128","author":"Kovacs","year":"2008","journal-title":"Clin Immunol"},{"key":"2021122010061718200_cei12324-bib-0013","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/BOR.0b013e32832eba21","article-title":"Pathogenesis of Sjogren's syndrome","volume":"21","author":"Nikolov","year":"2009","journal-title":"Curr Opin Rheumatol"},{"key":"2021122010061718200_cei12324-bib-0014","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/j.intimp.2007.07.018","article-title":"Anti-brain cholinergic auto antibodies from primary Sjogren syndrome sera modify simultaneously cerebral nitric oxide and prostaglandin biosynthesis","volume":"7","author":"Orman","year":"2007","journal-title":"Int Immunopharmacol"},{"key":"2021122010061718200_cei12324-bib-0015","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.molimm.2013.06.004","article-title":"The inhibitory effects of antimuscarinic autoantibodies in the sera of primary Sjogren syndrome patients on the gastrointestinal motility","volume":"56","author":"Park","year":"2013","journal-title":"Mol Immunol"},{"key":"2021122010061718200_cei12324-bib-0016","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1126\/science.3037705","article-title":"Identification of a family of muscarinic acetylcholine receptor genes","volume":"237","author":"Bonner","year":"1987","journal-title":"Science"},{"key":"2021122010061718200_cei12324-bib-0017","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/0896-6273(88)90190-0","article-title":"Cloning and expression of the human and rat m5 muscarinic acetylcholine receptor genes","volume":"1","author":"Bonner","year":"1988","journal-title":"Neuron"},{"key":"2021122010061718200_cei12324-bib-0018","doi-asserted-by":"crossref","first-page":"7328","DOI":"10.1016\/S0021-9258(18)83237-9","article-title":"Molecular cloning and expression of a fifth muscarinic acetylcholine receptor","volume":"264","author":"Liao","year":"1989","journal-title":"J Biol Chem"},{"key":"2021122010061718200_cei12324-bib-0019","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S0026-895X(25)10203-4","article-title":"Transfected muscarinic acetylcholine receptors selectively couple to Gi-type G proteins and Gq\/11","volume":"45","author":"Offermanns","year":"1994","journal-title":"Mol Pharmacol"},{"key":"2021122010061718200_cei12324-bib-0020","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/sj.bjp.0706780","article-title":"Muscarinic receptors: their distribution and function in body systems, and the implications for treating overactive bladder","volume":"148","author":"Abrams","year":"2006","journal-title":"Br J Pharmacol"},{"key":"2021122010061718200_cei12324-bib-0021","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.0300-9475.2004.01395.x","article-title":"Antibodies raised against the second extracellular loop of the human muscarinic M3 receptor mimic functional autoantibodies in Sjogren's syndrome","volume":"59","author":"Cavill","year":"2004","journal-title":"Scand J Immunol"},{"key":"2021122010061718200_cei12324-bib-0022","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1053\/gast.2002.36057","article-title":"Antibody-mediated gastrointestinal dysmotility in scleroderma","volume":"123","author":"Goldblatt","year":"2002","journal-title":"Gastroenterology"},{"key":"2021122010061718200_cei12324-bib-0023","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1002\/1529-0131(200007)43:7<1647::AID-ANR31>3.0.CO;2-P","article-title":"Inhibitory effects of muscarinic receptor autoantibodies on parasympathetic neurotransmission in Sjogren's syndrome","volume":"43","author":"Waterman","year":"2000","journal-title":"Arthritis Rheum"},{"key":"2021122010061718200_cei12324-bib-0024","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1002\/art.30282","article-title":"Antibodies interfering with the type 3 muscarinic receptor pathway inhibit gastrointestinal motility and cholinergic neurotransmission in Sjogren's syndrome","volume":"63","author":"Park","year":"2011","journal-title":"Arthritis Rheum"},{"key":"2021122010061718200_cei12324-bib-0025","first-page":"151","article-title":"Autoantibodies against lacrimal gland M3 muscarinic acetylcholine receptors in patients with primary Sjogren's syndrome","volume":"39","author":"Bacman","year":"1998","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2021122010061718200_cei12324-bib-0026","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1006\/clim.2002.5228","article-title":"Role of salivary IgA in the pathogenesis of Sjogren syndrome","volume":"104","author":"Berra","year":"2002","journal-title":"Clin Immunol"},{"key":"2021122010061718200_cei12324-bib-0027","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1038\/labinvest.3700173","article-title":"Inhibitory effects of autoantibodies on the muscarinic receptors in Sjogren's syndrome","volume":"84","author":"Li","year":"2004","journal-title":"Lab Invest"},{"key":"2021122010061718200_cei12324-bib-0028","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1365-2249.2010.04188.x","article-title":"New epitopes and function of anti-M3 muscarinic acetylcholine receptor antibodies in patients with Sj\u00f6gren's syndrome","volume":"162","author":"Tsuboi","year":"2010","journal-title":"Clin Exp Immunol"},{"key":"2021122010061718200_cei12324-bib-0029","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1093\/rheumatology\/keh389","article-title":"Putative anti-muscarinic antibodies cannot be detected in patients with primary Sjogren's syndrome using conventional immunological approaches","volume":"43","author":"Dawson","year":"2004","journal-title":"Rheumatology"},{"key":"2021122010061718200_cei12324-bib-0030","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.bbadis.2011.11.012","article-title":"Autoantibodies in primary Sjogren's syndrome patients induce internalization of muscarinic type 3 receptors","volume":"1822","author":"Jin","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"2021122010061718200_cei12324-bib-0031","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1128\/JCM.44.5.1665-1673.2006","article-title":"Development and optimization of high-throughput methods to measure Plasmodium falciparum-specific growth inhibitory antibodies","volume":"44","author":"Persson","year":"2006","journal-title":"J Clin Microbiol"},{"key":"2021122010061718200_cei12324-bib-0032","first-page":"321","article-title":"Muscarinic acetylcholine receptor antibodies as a new marker of dry eye Sjogren syndrome","volume":"42","author":"Bacman","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2021122010061718200_cei12324-bib-0033","first-page":"1342","article-title":"Failure to detect antibodies to extracellular loop peptides of the muscarinic M3 receptor in primary Sjogren's syndrome","volume":"29","author":"Cavill","year":"2002","journal-title":"J Rheumatol"},{"key":"2021122010061718200_cei12324-bib-0034","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1093\/rheumatology\/keq420","article-title":"Diagnostic significance of measuring antibodies to cyclic type 3 muscarinic acetylcholine receptor peptides in primary Sjogren's syndrome","volume":"50","author":"He","year":"2011","journal-title":"Rheumatology"},{"key":"2021122010061718200_cei12324-bib-0035","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1136\/ard.2008.096545","article-title":"Muscarinic-3 acetylcholine receptor autoantibody in patients with systemic sclerosis: contribution to severe gastrointestinal tract dysmotility","volume":"68","author":"Kawaguchi","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"2021122010061718200_cei12324-bib-0036","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1093\/rheumatology\/keh672","article-title":"Clinical associations of autoantibodies to human muscarinic acetylcholine receptor 3(213\u2013228) in primary Sjogren's syndrome","volume":"44","author":"Kovacs","year":"2005","journal-title":"Rheumatology"},{"key":"2021122010061718200_cei12324-bib-0037","first-page":"2490","article-title":"Serum IgA against type 3 muscarinic acetylcholine receptor is a novel marker in diagnosis of Sjogren's syndrome","volume":"124","author":"Li","year":"2011","journal-title":"Chin Med J"},{"key":"2021122010061718200_cei12324-bib-0038","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jaut.2004.11.005","article-title":"A peptide of human muscarinic acetylcholine receptor 3 is antigenic in primary Sjogren's syndrome","volume":"24","author":"Marczinovits","year":"2005","journal-title":"J Autoimmun"},{"key":"2021122010061718200_cei12324-bib-0039","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1136\/ard.2004.025478","article-title":"Muscarinic acetylcholine receptor autoantibodies in patients with Sjogren's syndrome","volume":"64","author":"Naito","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"2021122010061718200_cei12324-bib-0040","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1136\/ard.2010.129049","article-title":"Peptide-based ELISAs are not sensitive and specific enough to detect muscarinic receptor type 3 autoantibodies in serum from patients with Sjogren's syndrome","volume":"70","author":"Roescher","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"2021122010061718200_cei12324-bib-0041","doi-asserted-by":"crossref","first-page":"7260","DOI":"10.1073\/pnas.97.13.7260","article-title":"Chimeric green fluorescent protein-aequorin as bioluminescent Ca2+ reporters at the single-cell level","volume":"97","author":"Baubet","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"2021122010061718200_cei12324-bib-0042","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1042\/bj3570687","article-title":"Measurement of proteases using chemiluminescence-resonance-energy-transfer chimaeras between green fluorescent protein and aequorin","volume":"357","author":"Waud","year":"2001","journal-title":"Biochem J"},{"key":"2021122010061718200_cei12324-bib-0043","doi-asserted-by":"crossref","first-page":"e19520","DOI":"10.1371\/journal.pone.0019520","article-title":"Red fluorescent protein-aequorin fusions as improved bioluminescent Ca2+ reporters in single cells and mice","volume":"6","author":"Bakayan","year":"2011","journal-title":"PLOS ONE"},{"key":"2021122010061718200_cei12324-bib-0044","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/jcp.1030590302","article-title":"Extraction, purification and properties of aequorin, a bioluminescent protein from the luminous hydromedusan, Aequorea","volume":"59","author":"Shimomura","year":"1962","journal-title":"J Cell Comp Physiol"},{"key":"2021122010061718200_cei12324-bib-0045","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1021\/bi00709a028","article-title":"Intermolecular energy transfer in the bioluminescent system of Aequorea","volume":"13","author":"Morise","year":"1974","journal-title":"Biochemistry"},{"key":"2021122010061718200_cei12324-bib-0046","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/acr.21591","article-title":"American College of Rheumatology classification criteria for Sjogren's syndrome: a data-driven, expert consensus approach in the Sjogren's International Collaborative Clinical Alliance cohort","volume":"64","author":"Shiboski","year":"2012","journal-title":"Arthritis Care Res"},{"key":"2021122010061718200_cei12324-bib-0047","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/art.38098","article-title":"2013 classification criteria for systemic sclerosis: an American College of Rheumatology\/European League against Rheumatism collaborative initiative","volume":"65","author":"van den Hoogen","year":"2013","journal-title":"Arthritis Rheum"},{"key":"2021122010061718200_cei12324-bib-0048","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/j.humimm.2013.06.020","article-title":"Autoimmune associations and autoantibody screening show focused recognition in patient subgroups with generalized myasthenia gravis","volume":"74","author":"Klein","year":"2013","journal-title":"Hum Immunol"},{"key":"2021122010061718200_cei12324-bib-0049","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/j.psyneuen.2009.03.011","article-title":"Increased prevalence of antibodies to central nervous system tissue and gangliosides in Hashimoto's thyroiditis compared to other thyroid illnesses","volume":"34","author":"Mussig","year":"2009","journal-title":"Psychoneuroendocrinology"},{"key":"2021122010061718200_cei12324-bib-0050","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1172\/JCI4106","article-title":"Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor","volume":"103","author":"Wallukat","year":"1999","journal-title":"J Clin Invest"},{"key":"2021122010061718200_cei12324-bib-0051","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/227680a0","article-title":"Cleavage of structural proteins during the assembly of the head of bacteriophage T4","volume":"227","author":"Laemmli","year":"1970","journal-title":"Nature"},{"key":"2021122010061718200_cei12324-bib-0052","doi-asserted-by":"crossref","first-page":"4350","DOI":"10.1073\/pnas.76.9.4350","article-title":"Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications","volume":"76","author":"Towbin","year":"1979","journal-title":"Proc Natl Acad Sci USA"},{"key":"2021122010061718200_cei12324-bib-0053","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/sj.bjp.0702166","article-title":"Interaction of neuromuscular blocking drugs with recombinant human m1-m5 muscarinic receptors expressed in Chinese hamster ovary cells","volume":"125","author":"Cembala","year":"1998","journal-title":"Br J Pharmacol"},{"key":"2021122010061718200_cei12324-bib-0054","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/S0006-2952(97)00250-5","article-title":"Influence of acute and chronic ethanol treatment on muscarinic responses and receptor expression in Chinese hamster ovary cells","volume":"54","author":"Chang","year":"1997","journal-title":"Biochem Pharmacol"},{"key":"2021122010061718200_cei12324-bib-0055","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/978-1-61779-921-1_13","article-title":"Transient expression technologies: past, present, and future","volume":"899","author":"Geisse","year":"2012","journal-title":"Methods Mol Biol"},{"key":"2021122010061718200_cei12324-bib-0056","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1042\/bj0341248","article-title":"The serum proteins in multiple myelomatosis","volume":"34","author":"Kekwick","year":"1940","journal-title":"Biochem J"},{"key":"2021122010061718200_cei12324-bib-0057","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1016\/j.molimm.2011.04.024","article-title":"Complement activation by (auto-) antibodies","volume":"48","author":"Daha","year":"2011","journal-title":"Mol Immunol"},{"key":"2021122010061718200_cei12324-bib-0058","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0022-1759(83)90401-5","article-title":"Use of ATPase-associated antigen (M2) for detection of antimitochondrial antibodies in primary biliary cirrhosis by fluorometric immunoassay","volume":"64","author":"Klein","year":"1983","journal-title":"J Immunol Methods"},{"key":"2021122010061718200_cei12324-bib-0059","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1038\/ajg.2010.276","article-title":"Update on serologic testing in celiac disease","volume":"105","author":"Leffler","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"2021122010061718200_cei12324-bib-0060","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.autrev.2012.08.002","article-title":"The clinical relevance of IgA anticardiolipin and IgA anti-beta2 glycoprotein I antiphospholipid antibodies: a systematic review","volume":"12","author":"Meijide","year":"2013","journal-title":"Autoimmun Rev"},{"key":"2021122010061718200_cei12324-bib-0061","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/1471-230X-12-152","article-title":"Analysis of the clinical relevance of antimitochondrial antibodies to the beta- and gamma-subunits of the F1F0-ATPase in patients with primary biliary cirrhosis","volume":"12","author":"Nann","year":"2012","journal-title":"BMC Gastroenterol"},{"key":"2021122010061718200_cei12324-bib-0062","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/B978-0-12-407681-5.00006-4","article-title":"Glycoprotein 2 antibodies in Crohn's disease","volume":"60","author":"Roggenbuck","year":"2013","journal-title":"Adv Clin Chem"},{"key":"2021122010061718200_cei12324-bib-0063","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.cca.2009.06.035","article-title":"Autoantibodies to asialoglycoprotein receptor (ASGPR) measured by a novel ELISA \u2013 revival of a disease-activity marker in autoimmune hepatitis","volume":"408","author":"Hausdorf","year":"2009","journal-title":"Clin Chim Acta"},{"key":"2021122010061718200_cei12324-bib-0064","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1111\/j.1476-5381.2012.01828.x","article-title":"Drug-like actions of autoantibodies against receptors of the autonomous nervous system and their impact on human heart function","volume":"166","author":"Herda","year":"2012","journal-title":"Br J Pharmacol"},{"key":"2021122010061718200_cei12324-bib-0065","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.autrev.2009.03.012","article-title":"TSH receptor autoantibodies","volume":"9","author":"Michalek","year":"2009","journal-title":"Autoimmun Rev"},{"key":"2021122010061718200_cei12324-bib-0066","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/1471-230X-10-120","article-title":"Autoantibodies to muscarinic acetylcholine receptors found in patients with primary biliary cirrhosis","volume":"10","author":"Berg","year":"2010","journal-title":"BMC Gastroenterol"},{"key":"2021122010061718200_cei12324-bib-0067","first-page":"567A","article-title":"Demonstration of functional antibodies inhibiting the human muscarinic acetylcholine receptor of the M3 type (hm3AchR) in sera from patients with autoimmune liver disorders","volume":"58","author":"Preuss","year":"2013","journal-title":"Hepatology"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fcei.12324","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/177\/1\/179\/41793003\/cei12324.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/177\/1\/179\/41793003\/cei12324.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T02:23:28Z","timestamp":1746152608000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/177\/1\/179\/6421245"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,9]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2014,6,9]]},"published-print":{"date-parts":[[2014,6,9]]}},"URL":"https:\/\/doi.org\/10.1111\/cei.12324","relation":{},"ISSN":["0009-9104","1365-2249"],"issn-type":[{"value":"0009-9104","type":"print"},{"value":"1365-2249","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2014,7]]},"published":{"date-parts":[[2014,6,9]]}}}